Beta Bionics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Beta Bionics, Inc. (BBNX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-29
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$415.00K, a 120.91% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$951.00K, a 158.70% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $413.00K, a 63.39% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.79M, a 128.32% increase year-over-year.
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $5.81M, a 103.86% increase from fiscal 2024.
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.85M, a 628.64% increase from fiscal 2023.
- Beta Bionics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $391.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$1.37M 10-Q · filed 2026-07-29 | -$953.00K derived: sum of 3 quarters · filed 2026-07-29 | $837.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$951.00K 10-Q · filed 2026-04-21 | -$538.00K derived: sum of 2 quarters · filed 2026-04-21 | $1.25M derived: sum of 3 quarters · filed 2026-04-21 | $3.24M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.20M derived: sum of 2 quarters · filed 2026-02-24 | $4.19M derived: sum of 3 quarters · filed 2026-07-29 | $5.81M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.77M derived: sum of 2 quarters · filed 2026-07-29 | $5.39M 10-Q · filed 2025-10-28 | $6.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $3.60M 10-Q · filed 2026-07-29 | $4.73M derived: sum of 3 quarters · filed 2026-07-29 | $5.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $1.62M 10-Q · filed 2026-04-21 | $2.75M derived: sum of 2 quarters · filed 2026-04-21 | $3.53M derived: sum of 3 quarters · filed 2026-04-21 | $3.41M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.91M derived: sum of 2 quarters · filed 2026-02-24 | $1.79M derived: sum of 3 quarters · filed 2026-02-24 | $2.85M 10-K · filed 2026-02-24 |
| 2024-09-30 | $784.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $660.00K derived: sum of 2 quarters · filed 2025-10-28 | $1.72M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $937.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $391.00K 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |